Lipid changes in patients initiating efavirenz- and indinavir-based antiretroviral regimens (Q44309075)

1 December 2017

Lipid changes in patients initiating efavirenz- and indinavir-based antiretroviral regimens (English)

1 reference

1 December 2017

anti-retroviral agent

0 references

1 reference

1 reference

Karen T Tashima

1

1 reference

1 December 2017

Linda Bausserman

2

1 reference

1 December 2017

Elizabeth N Alt

3

1 reference

1 December 2017

Esther Aznar

4

1 reference

1 December 2017

Timothy P Flanigan

5

1 reference

1 December 2017

language of work or name

1 reference

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

4

1 reference

1 December 2017

1

1 reference

1 December 2017

29-36

1 reference

Alterations in serum levels of lipids and lipoproteins with indinavir therapy for human immunodeficiency virus-infected patients

1 December 2017

1 reference

https://api.crossref.org/works/10.1310%2FF2V7-3R46-VX6J-241R

Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF2V7-3R46-VX6J-241R

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF2V7-3R46-VX6J-241R

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF2V7-3R46-VX6J-241R

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF2V7-3R46-VX6J-241R

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF2V7-3R46-VX6J-241R

Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF2V7-3R46-VX6J-241R

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF2V7-3R46-VX6J-241R

Disorders of glucose metabolism in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF2V7-3R46-VX6J-241R

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF2V7-3R46-VX6J-241R

Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF2V7-3R46-VX6J-241R

Sex differences in HAART-associated dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FF2V7-3R46-VX6J-241R

10.1310/F2V7-3R46-VX6J-241R

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference